entertainment -WSS

entertainment

author：entertainment 2025-09-29 21:13:40 - browse：748

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： The high cost of giving birth even with insurance

leisure time

WSS

Nick Jonas talks about managing diabetes along with his career

Moonlake's readout produced a cash windfall. Risks remain

Jerome Adams on the need for new antivirals for Covid

Researchers CRISPR chickens in bid to protect them from bird flu

STAT Readout: Today's biotech news includes Sana and Amylyx

Hollywood unions extend contract negotiations for actors

hotspot

entertainment

focus

Affirmative action in medical school literally saved lives

In age of alternative facts, a scholarly course on calling out crap

United colonoscopy coverage change 'may cost lives,' doctors say

Massive project maps cells in human brain in unprecedented detail

Trump demands the U.S. pay no more for drugs than other countries … again

Tori Bowie and the unacceptable rates of Black maternal death

Hollywood unions extend contract negotiations for actors

How one medical school became remarkably diverse

Wildfire smoke exposes gaps in outdoor worker protections

Researchers CRISPR chickens in bid to protect them from bird flu

knowledge

Female surgeons have lower rates of long

How doctors and nurses shape Google's AI

Duchenne breakthrough therapy leaves behind pioneering families

Medicare to cover more brain scans related to Alzheimer’s drugs

A fraught question for the kids of Alzheimer’s: Is it coming for us?

In age of alternative facts, a scholarly course on calling out crap

focus

leisure time

knowledge

Wikipedia